144 related articles for article (PubMed ID: 32366107)
1. Efficacy of cyclophosphamide, doxorubicin, and cisplatin for adenoid cystic carcinoma, and their relationship with the pre-chemotherapy tumor growth rate.
Ha H; Keam B; Ock CY; Heo DS
Chin Clin Oncol; 2020 Apr; 9(2):15. PubMed ID: 32366107
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer.
Debaere D; Vander Poorten V; Nuyts S; Hauben E; Schoenaers J; Schöffski P; Clement PM
B-ENT; 2011; 7(1):1-6. PubMed ID: 21563549
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin.
Dreyfuss AI; Clark JR; Fallon BG; Posner MR; Norris CM; Miller D
Cancer; 1987 Dec; 60(12):2869-72. PubMed ID: 2824016
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck.
de Haan LD; De Mulder PH; Vermorken JB; Schornagel JH; Vermey A; Verweij J
Head Neck; 1992; 14(4):273-7. PubMed ID: 1381339
[TBL] [Abstract][Full Text] [Related]
5. Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel.
Fukuda N; Fujiwara Y; Wang X; Ohmoto A; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Takahashi S
Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3037-3043. PubMed ID: 33219858
[TBL] [Abstract][Full Text] [Related]
6. Adenoid cystic carcinoma of the esophagus. Complete response to combination chemotherapy.
Petursson SR
Cancer; 1986 Apr; 57(8):1464-7. PubMed ID: 3004692
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma.
Tse DT; Kossler AL; Feuer WJ; Benedetto PW
Ophthalmology; 2013 Jul; 120(7):1313-23. PubMed ID: 23582989
[TBL] [Abstract][Full Text] [Related]
8. The role of hexamethylmelamine in the combination chemotherapy of advanced ovarian cancer: a comparison of hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin (H-CAP) versus cyclophosphamide, doxorubicin, and cisplatin (CAP).
Hainsworth JD; Jones HW; Burnett LS; Johnson DH; Greco FA
Am J Clin Oncol; 1990 Oct; 13(5):410-5. PubMed ID: 2121019
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group.
Feld R; Rubinstein L; Thomas PA
J Natl Cancer Inst; 1993 Feb; 85(4):299-306. PubMed ID: 8381187
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for recurrent adeno- and adenoidcystic carcinomas in the head and neck.
Tsukuda M; Kokatsu T; Ito K; Mochimatsu I; Kubota A; Sawaki S
J Cancer Res Clin Oncol; 1993; 119(12):756-8. PubMed ID: 8408188
[TBL] [Abstract][Full Text] [Related]
11. Does intra-arterial chemotherapy improve survival for lacrimal gland adenoid cystic carcinoma?
Esmaeli B
Ophthalmology; 2014 Jan; 121(1):e7-e8. PubMed ID: 24268857
[No Abstract] [Full Text] [Related]
12. Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study.
Savarese T; Abate A; Basnet RM; Lorini L; Gurizzan C; Tomasoni M; Lombardi D; Tomasini D; Zizioli D; Memo M; Berruti A; Bonini SA; Sigala S; Bossi P
Sci Rep; 2022 Jun; 12(1):9951. PubMed ID: 35705678
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin combination chemotherapy in squamous cell carcinoma and adenoid cystic carcinoma of the skin.
Ikegawa S; Saida T; Obayashi H; Sasaki A; Esumi H; Ikeda S; Kiyohara Y; Hayasaka K; Ishihara K
J Dermatol; 1989 Jun; 16(3):227-30. PubMed ID: 2551943
[TBL] [Abstract][Full Text] [Related]
14. A Favorable Response to Levetiracetam in a Patient with Metastatic Adenoid Cystic Carcinoma.
Sakata S; Saeki S; Terasaki Y; Natori Y; Fujii K
Intern Med; 2018 Mar; 57(5):721-724. PubMed ID: 29151513
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma.
Hill ME; Constenla DO; A'Hern RP; Henk JM; Rhys-Evans P; Breach N; Archer D; Gore ME
Oral Oncol; 1997 Jul; 33(4):275-8. PubMed ID: 9307718
[TBL] [Abstract][Full Text] [Related]
16. Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma.
Ross PJ; Teoh EM; A'hern RP; Rhys-Evans PH; Harrington KJ; Nutting CM; Gore ME
Clin Oncol (R Coll Radiol); 2009 May; 21(4):311-4. PubMed ID: 19201585
[TBL] [Abstract][Full Text] [Related]
17. Adenoid cystic carcinoma of the lacrimal gland: rare … lethal … cured?
Bradley EA; Bradley DJ
Ophthalmology; 2013 Jul; 120(7):1311-2. PubMed ID: 23823505
[No Abstract] [Full Text] [Related]
18. Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial.
International Collaborative Ovarian Neoplasm Group
Lancet; 2002 Aug; 360(9332):505-15. PubMed ID: 12241653
[TBL] [Abstract][Full Text] [Related]
19. A comparison of hexamethylmelamine (altretamine), cyclophosphamide, doxorubicin, and cisplatin (H-CAP) vs. cyclophosphamide, doxorubicin, and cisplatin (CAP) in advanced ovarian cancer.
Greco FA; Johnson DH; Hainsworth JD
Cancer Treat Rev; 1991 Mar; 18 Suppl A():47-55. PubMed ID: 1904309
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
